FIRAPY Debuts at WHX Dubai 2026 with a Focus on Innovative Care for Dialysis Patients
On 9–10 February 2026, FIRAPY joined Unex Corporation (Japan) at World Health Expo – WHX Dubai 2026, held at the Dubai Exhibition Centre, Expo City Dubai. This was FIRAPY’s first time participating in WHX Dubai, marking an important step in expanding our presence in the Middle East and surrounding regions.
WHX Dubai (World Health Expo) is one of the region’s most important healthcare exhibitions, bringing together thousands of healthcare professionals, industry leaders, and innovators from more than 100 countries. The event combines a large-scale trade show with conferences and forums that highlight new technologies, clinical best practices, and emerging models of care.
Within the shared exhibition area, FIRAPY and Unex each showcased their own products and solutions.
FIRAPY’s booth focused on the theme:
“An Innovative Therapy for Dialysis Patients”
Visitors could see how FIRAPY is applied in real-world dialysis units through photos, clinical examples, and on-site discussions about workflow integration and patient selection.
Unex, meanwhile, presented its own FMD technologies, giving visitors a broader view of innovation in vascular care coming from Japan and Taiwan.
Strong Interest from Emerging and Established Markets
During the first two days of WHX Dubai, the FIRAPY booth welcomed a continuous stream of visitors, including
distributors and potential partners from India, Italy, Pakistan, Morocco, Bosnia and Herzegovina, the United Arab Emirates, Saudi Arabia, Lebanon, and Libya.
Discussions covered:
- How to introduce FIRAPY as a non-invasive option for vascular access care
- Integration into existing dialysis workflows and staffing patterns
- Evidence from international guidelines and clinical studies
- Opportunities for pilot projects and local clinical evaluation
We were deeply impressed by the energy of the exhibition and the proactive engagement of attendees. Many visitors came prepared with detailed questions about clinical outcomes, patient selection, and implementation in both public and private dialysis centers—turning booth visits into serious, project-oriented conversations.
We are grateful to all the clinicians, distributors, and industry colleagues who visited our booth, and to Unex for sharing the exhibition space in Dubai. FIRAPY remains committed to bringing evidence-based, practical, and patient-friendly FIR therapy to dialysis patients worldwide.
Want to know more?
Contact us for more detail
